Gastroenterology · Chronic Pancreatitis

The Diagnostic Journey: Solving the Mystery of Your Pancreatitis

At a Glance

Idiopathic chronic pancreatitis means no clear cause has been found with testing so far. Doctors use the TIGAR-O framework, imaging, selected genetic tests, endoscopic ultrasound, and fecal elastase to look for hidden causes and pancreatic function problems.

Finding the cause of chronic pancreatitis is a process of elimination. Because many different factors can lead to the same type of pancreatic damage, doctors use a systematic checklist. When you are told your pancreatitis is idiopathic, it means your medical team has not found a match with the testing completed so far ^[1]^[2]. It does not guarantee that every single genetic, autoimmune, or metabolic possibility has been exhaustively tested.

The TIGAR-O Checklist

To organize the search for a cause, specialists use the TIGAR-O framework. This acronym represents the major categories of risk factors:

T (Toxic-metabolic): Includes long-term alcohol use, cigarette smoking, high calcium levels (hypercalcemia), and very high triglycerides (fats in the blood) ^[3]^[4].
I (Idiopathic): Cases where no cause is found after evaluation ^[1].
G (Genetic): Inherited mutations or susceptibility variants ^[2].
A (Autoimmune): A condition where the body’s immune system attacks the pancreas, often requiring specific blood tests (like IgG4) or biopsies to confirm ^[5].
R (Recurrent and severe acute pancreatitis): Damage left behind by multiple previous attacks of acute pancreatitis ^[1].
O (Obstructive): Physical blockages like stones, strictures, or tumors. (Note: Pancreas divisum, a birth variant where the ducts don’t fuse normally, is sometimes grouped here, but it is a relatively common incidental finding and its actual role in causing disease is highly debated ^[6]^[7].)

The Role of Advanced Imaging

Imaging is the primary way doctors see the structural “footprints” of chronic pancreatitis.

1. Computed Tomography (CT)

A CT scan is often the first test used. It is excellent at showing late-stage changes, such as calcifications (hardened calcium deposits) and major complications like fluid collections ^[6]^[8]. However, a normal CT scan does not rule out early or mild chronic pancreatitis ^[9].

2. MRI and MRCP

An MRI combined with MRCP (Magnetic Resonance Cholangiopancreatography) uses magnets to create a detailed map of the pancreatic and bile ducts, which is particularly useful for ductal anatomy ^[10]^[11].

Secretin-MRCP: In some specialized centers, a hormone called secretin is injected to stimulate the pancreas to produce fluid. This provides indirect information about duct compliance and function, but it is an adjunct test rather than a definitive measure of total enzyme production ^[6]^[7].

3. Endoscopic Ultrasound (EUS)

If symptoms strongly suggest CP but CT and MRI are normal, an EUS may be used. A doctor passes a flexible tube with an ultrasound probe down your throat ^[12]. The probe sits right next to the pancreas, allowing it to see subtle parenchymal or ductal changes ^[13]^[14]. However, EUS findings can be nonspecific; features like small strands or cysts can be found in people without clinically meaningful disease. Results must be carefully interpreted by an expert alongside your symptoms and history ^[13].

Genetic Testing: Looking Deeper

Genetic testing is often considered when patients have unexplained recurrent acute pancreatitis, young-onset disease, or a strong family history ^[2]^[15]. Because the implications of genetic testing can affect your privacy and your family, it should ideally involve genetic counseling.

Commonly tested genes include PRSS1 (strongly linked to hereditary pancreatitis), and SPINK1, CTRC, or CFTR (which often act as risk modifiers rather than sole causes) ^[16]^[17]^[18]. Keep in mind that finding a variant may not immediately change your day-to-day treatment, and a negative panel does not completely exclude a genetic contribution.

Testing Pancreatic Function: Fecal Elastase

While imaging looks at the structure, the Fecal Elastase-1 (FE-1) test looks at exocrine function ^[19].

The Numbers: A stool sample is tested for elastase, an enzyme produced by the pancreas ^[20]. A result over 200 μg/g is generally normal ^[21]. A result below 100 μg/g strongly suggests Exocrine Pancreatic Insufficiency (EPI) ^[22]^[23].
The Indeterminate Zone: Results between 100 and 200 μg/g are indeterminate. A single normal or indeterminate result doesn’t completely rule out mild EPI.
The Caveat: The test must be performed on a formed (solid) stool. Watery diarrhea can “dilute” the enzyme, leading to a falsely low result ^[24]^[25].

A low result should always be discussed with your doctor in the context of your symptoms (weight loss, oily stools) before starting any enzyme replacement therapy. You should not independently start or escalate prescription enzymes based on this number alone.

Common questions in this guide

What does idiopathic chronic pancreatitis mean?

It means doctors have not identified a clear cause after the tests completed so far. It does not prove that every genetic, autoimmune, metabolic, or structural cause has been ruled out, and the evaluation may depend on your history and symptoms.

How does the TIGAR-O checklist help find a cause of chronic pancreatitis?

TIGAR-O helps clinicians organize possible causes of chronic pancreatitis into toxic-metabolic, idiopathic, genetic, autoimmune, recurrent acute, and obstructive categories. It can guide which history questions, blood tests, imaging studies, or genetic evaluations may be considered.

Can chronic pancreatitis still be present if my CT and MRI are normal?

Yes. A normal CT does not rule out early or mild chronic pancreatitis. If symptoms remain concerning despite normal CT and MRI, an expert may consider an endoscopic ultrasound or a specialized MRI of the pancreatic ducts, with results interpreted alongside your history.

When might genetic testing be useful for unexplained pancreatitis?

Genetic testing is often considered when pancreatitis starts at a young age, acute attacks keep recurring without an explanation, or several relatives have pancreatitis. Genetic counseling can explain what results may mean for you and your family; commonly tested genes include PRSS1, SPINK1, CTRC, and CFTR.

How should I understand my fecal elastase result?

Fecal elastase measures a pancreatic enzyme in stool and helps assess digestive function. Results above 200 micrograms per gram are generally normal, results below 100 strongly suggest exocrine pancreatic insufficiency, and 100 to 200 is an indeterminate range. Watery stool can dilute the sample and cause a falsely low result, so discuss the number and sample consistency with your clinician before starting or changing prescription enzymes.

Does pancreas divisum prove that it caused my pancreatitis?

No. Pancreas divisum is a common birth-related difference in how the pancreatic ducts join, and it is often found incidentally. Its role in causing chronic pancreatitis is debated, so doctors interpret it alongside symptoms, other test results, and your history.

Can smoking or alcohol matter if no cause of pancreatitis is found?

Yes. Smoking and alcohol exposure are part of the toxic-metabolic assessment, and your clinician may recommend addressing them even when no single cause has been identified. Share an accurate history so recommendations reflect your situation.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Idiopathic chronic pancreatitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Which categories of the TIGAR-O framework have we formally tested for in my case?
2.Based on my age and family history, should I meet with a genetic counselor to discuss testing for variants like PRSS1, SPINK1, or CFTR?
3.Since my CT/MRI was normal, is there clinical value in pursuing an EUS or secretin-MRCP, or does it not change my current treatment plan?
4.What was my specific fecal elastase-1 number, and was the stool sample formed enough to give an accurate result?
5.Are there specific lifestyle factors, like smoking or minor alcohol use, that you recommend I address to slow disease progression?

Key takeaways

Idiopathic chronic pancreatitis means no clear cause has been found with the evaluation completed so far, not that every possible cause has been excluded.
The TIGAR-O framework organizes potential causes into toxic-metabolic, genetic, autoimmune, recurrent acute, and obstructive categories, along with idiopathic cases.
A normal CT does not rule out early or mild chronic pancreatitis, and selected patients with normal CT and MRI may undergo endoscopic ultrasound or secretin-MRCP.
Genetic testing is most often considered for young-onset disease, unexplained recurrent acute pancreatitis, or a strong family history and is best paired with genetic counseling.
Fecal elastase must be interpreted with stool consistency because watery samples can falsely lower the result; values below 100 micrograms per gram strongly suggest exocrine pancreatic insufficiency.

References (25)

1
Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.
Whitcomb DC,
Clinical and translational gastroenterology 2019; (10(6)):e00027 doi:10.14309/ctg.0000000000000027.
PMID: 31166201
2
[Identical Variants Different Disease Course - Genetics of Chronic Pancreatitis].
Beer S, Mössner J
Deutsche medizinische Wochenschrift (1946) 2017; (142(9)):673-677 doi:10.1055/s-0043-100810.
PMID: 28454201
3
Smoking as the most important risk factor for chronic pancreatitis in the general population.
Hansen SEJ, Nordestgaard BG, Langsted A
European journal of epidemiology 2023; (38(1)):95-107 doi:10.1007/s10654-022-00945-7.
PMID: 36593333
4
Chronic pancreatitis.
Kleeff J, Whitcomb DC, Shimosegawa T, et al.
Nature reviews. Disease primers 2017; (3()):17060 doi:10.1038/nrdp.2017.60.
PMID: 28880010
5
Germline multigene panel testing in acute and chronic pancreatitis.
Ramsey ML, Heald B, Gokun Y, et al.
PloS one 2024; (19(8)):e0307076 doi:10.1371/journal.pone.0307076.
PMID: 39172977
6
Guidelines for the Diagnostic Cross Sectional Imaging and Severity Scoring of Chronic Pancreatitis.
Frøkjær JB, Akisik F, Farooq A, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018; (18(7)):764-773 doi:10.1016/j.pan.2018.08.012.
PMID: 30177434
7
Secretin-Enhanced MRCP: How and Why-AJR Expert Panel Narrative Review.
Swensson J, Zaheer A, Conwell D, et al.
AJR. American journal of roentgenology 2021; (216(5)):1139-1149 doi:10.2214/AJR.20.24857.
PMID: 33263419
8
Imaging of Fibrosis in Chronic Pancreatitis.
Yamashita Y, Ashida R, Kitano M
Frontiers in physiology 2021; (12()):800516 doi:10.3389/fphys.2021.800516.
PMID: 35082692
9
Diagnosing Chronic Pancreatitis.
Anaizi A, Hart PA, Conwell DL
Digestive diseases and sciences 2017; (62(7)):1713-1720 doi:10.1007/s10620-017-4493-2.
PMID: 28315036
10
Chronic Pancreatitis: What the Clinician Wants to Know from MR Imaging.
Tirkes T
Magnetic resonance imaging clinics of North America 2018; (26(3)):451-461 doi:10.1016/j.mric.2018.03.012.
PMID: 30376981
11
Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis.
Issa Y, Kempeneers MA, van Santvoort HC, et al.
European radiology 2017; (27(9)):3820-3844 doi:10.1007/s00330-016-4720-9.
PMID: 28130609
12
Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications.
Pawelec N, Durko Ł, Małecka-Wojciesko E
Cancers 2025; (17(11)) doi:10.3390/cancers17111891.
PMID: 40507369
13
International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.
Mel Wilcox C, Gress T, Boermeester M, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2020; (20(5)):822-827 doi:10.1016/j.pan.2020.05.025.
PMID: 32631791
14
EUS and secretin endoscopic pancreatic function test predict evolution to overt structural changes of chronic pancreatitis in patients with nondiagnostic baseline imaging.
Monachese M, Lee PJ, Harris K, et al.
Endoscopic ultrasound 2021; (10(2)):116-123 doi:10.4103/EUS-D-20-00138.
PMID: 33885007
15
[Pathogenesis of chronic pancreatitis].
Rosendahl J, Witt H
Der Internist 2021; (62(10)):1007-1014 doi:10.1007/s00108-021-01150-6.
PMID: 34524468
16
[Practical Genetic Testing in Gastroenterology].
Hohmann M, Schmelz R, Hampe J, Zeißig S
Deutsche medizinische Wochenschrift (1946) 2018; (143(20)):1477-1480 doi:10.1055/a-0588-1684.
PMID: 30286498
17
Diagnosis and Management of Chronic Pancreatitis: A Review.
Singh VK, Yadav D, Garg PK
JAMA 2019; (322(24)):2422-2434 doi:10.1001/jama.2019.19411.
PMID: 31860051
18
Genetic Evaluation of Pancreatitis.
Fu Y, Lucas AL
Gastrointestinal endoscopy clinics of North America 2022; (32(1)):27-43 doi:10.1016/j.giec.2021.08.006.
PMID: 34798985
19
Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis.
Diéguez-Castillo C, Jiménez-Luna C, Martín-Ruiz JL, et al.
Journal of clinical medicine 2020; (9(6)) doi:10.3390/jcm9062014.
PMID: 32604940
20
Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.
Othman MO, Harb D, Barkin JA
International journal of clinical practice 2018; (72(2)) doi:10.1111/ijcp.13066.
PMID: 29405509
21
Pancreatic exocrine insufficiency occurs in most patients following pancreaticoduodenectomy.
Kumar TK, Tewari M, Shukla SK, Mishra SP
Indian journal of cancer 2021; (58(4)):511-517 doi:10.4103/ijc.IJC_764_18.
PMID: 34975096
22
Diagnostic Accuracy of Fecal Elastase-1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta-Analysis.
de la Iglesia D, Agudo-Castillo B, Galego-Fernández M, et al.
United European gastroenterology journal 2025; (13(8)):1571-1582 doi:10.1002/ueg2.70061.
PMID: 40569793
23
Pancreatic exocrine insufficiency: Comparing fecal elastase 1 with 72-h stool for fecal fat estimation.
Chowdhury SD, Kurien RT, Ramachandran A, et al.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2016; (35(6)):441-444 doi:10.1007/s12664-016-0714-4.
PMID: 27878466
24
Preanalytical and analytical factors affecting elastase quantitation in stool.
Nelson HA
Clinical biochemistry 2024; (131-132()):110811 doi:10.1016/j.clinbiochem.2024.110811.
PMID: 39153524
25
Fecal elastase measurement- beware; A cautionary tale.
Wilcox CM, Tran H
The American journal of the medical sciences 2026; (371(1)):71-75 doi:10.1016/j.amjms.2025.10.015.
PMID: 41130566

This page is for informational purposes only and does not constitute medical advice about idiopathic chronic pancreatitis. Discuss your imaging, genetic testing, fecal elastase results, and treatment decisions with your clinician.

Guide Contents